Matinas BioPharma Holdings Inc MTNB:NYSE American

Last Price$0.84AMEX Previous Close - Last Trade as of 8:00PM ET 8/12/22

Today's Change-0.004(0.52%)
Bid (Size)$0.83 (5)
Ask (Size)$0.86 (1)
Day Low / High$0.84 - 0.86
Volume467.0 K

BioNTech, Matinas BioPharma Sign Exclusive Research Deal on Lipid Nanocrystal Technology

7:21AM ET 4/11/2022 MT Newswires
BioNTech SE (BNTX) and Matinas BioPharma Holdings, Inc. (MTNB) said Monday that they have signed an exclusive research agreement to evaluate the combination of mRNA formats and Matinas' proprietary platform technology.

The companies said they will closely collaborate on formulation, optimization and in vitro testing. Under the terms of the pact, BioNTech will provide an unspecified upfront access fee to work exclusively with the New Jersey-based firm, as well as additional research funding.

The two said they have also begun discussing a license agreement for Matinas' lipid nanocrystal platform technology.

Shares of Matinas BioPharma were up more than 9% in recent premarket trading, while shares of BioNTech were down nearly 2%.

Price: 167.44, Change: -2.82, Percent Change: -1.66